Hydroxychloroquine PK and exposure-response in pregnancies with lupus: the importance of adherence for neonatal outcomesStephen J. Balevic, Daniel González, Anil R. Maharaj et al.|Lupus Science & Medicine|2022Cited by 24
Hydroxychloroquine in Patients with Rheumatic Disease Complicated by COVID-19: Clarifying Target Exposures and the Need for Clinical TrialsStephen J. Balevic, Michael Cohen‐Wolkowiez, Christoph P. Hornik et al.|The Journal of Rheumatology|2020Cited by 21
Dr. Balevic, <i>et al</i> replyStephen J. Balevic, Michael Cohen‐Wolkowiez, Christoph P. Hornik et al.|The Journal of Rheumatology|2020Cited by 1
A PRELIMINARY STUDY OF THE RELATIONSHIP BETWEEN PLASMA MICROBIAL CELL-FREE DNA AND DISEASE ACTIVITY IN PATIENTS WITH LUPUSShiv D. Kale, Sivan Bercovici, Jennifer L Rogers et al.|The Journal of Rheumatology|2025Cited by 1